Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel Pd-catalyzed carbonylation route offers high yields and broad substrate scope for drug molecule synthesis, ensuring reliable supply chain solutions.
Novel biaryl ligand synthesis via Catellani reaction offers high enantioselectivity and scalable routes for pharmaceutical intermediates.
Novel heating-promoted synthesis of 2-trifluoromethyl quinoline. Metal-free, green chemistry, cost-effective for pharma intermediates. Reliable supply chain partner.
Patent CN115353482B reveals metal-free synthesis for high-purity pharmaceutical intermediates. Achieve substantial cost reduction and supply chain reliability.
Patent CN115925527B details a Ru-catalyzed method for high-purity API intermediate synthesis, offering significant cost reduction and supply chain reliability for global buyers.
Patent CN113307778A details a novel Mo-Cu co-catalyzed route for 3-trifluoromethyl-1,2,4-triazoles, offering mild conditions and high efficiency for reliable pharmaceutical intermediate suppliers.
Patent CN113121462A reveals a metal-free route for 5-trifluoromethyl-1,2,3-triazoles. This method offers cost reduction in pharmaceutical intermediate manufacturing via mild conditions.
Patent CN116640146B reveals efficient Pd-catalyzed route for trifluoromethyl chromone quinoline intermediates offering significant cost and supply chain advantages for pharmaceutical manufacturing.
Novel scalable route for tegoprazan key intermediate offering high purity ≥99% and simplified post-processing for reliable pharmaceutical supply chains.
Novel iodine-promoted method for 3,4,5-trisubstituted 1,2,4-triazoles offers cost-effective, scalable routes for API manufacturing without heavy metals.
Novel Pd-catalyzed multi-component route eliminates toxic CO gas, offering cost-effective production of high-purity pharmaceutical intermediates with superior scalability.
Patent CN115286553B reveals nickel-catalyzed carbonylation for indole synthesis. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel Pd-catalyzed carbonylation method for 2-CF3 quinazolinones. Enhances purity and reduces toxic gas usage for API manufacturing.
Patent CN112898192B details a novel Pd-catalyzed carbonylation route for N-acyl indoles, offering high yields and broad substrate tolerance for API intermediates.
Novel iodine-promoted synthesis of 5-trifluoromethyl-1,2,4-triazoles. Offers cost-effective, scalable routes for API intermediates without heavy metals.
Patent CN111592507A reveals a metal-free route to polysubstituted furans using BF3 catalysis, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN106938984B reveals a novel one-pot method for 5-substituted quinolines. Discover cost-effective manufacturing and high-purity supply chain solutions.
Patent CN115197124B reveals mild ammonium iodide catalysis for pyridine derivatives. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN110590621B details a mild copper-catalyzed route for 1,2-bis(arylsulfonyl) ethylene derivatives, offering cost reduction and scalable manufacturing for fine chemical intermediates.
Patent CN111410656B details a novel copper-catalyzed route to isoquinolinones, offering cost reduction in pharmaceutical intermediate manufacturing and scalable production capabilities.